Abstract
Pulmonary embolism (PE) and deep vein thrombosis (DVT) are two clinical presentations of venous thromboembolism (VTE) and share the same predisposing factors. In a study by our group, the Spanish National Discharge Database was used to assess the frequency and clinical impact of venous VTE after elective total knee (TKA) or hip (THA) arthroplasty. In all, 58,037 patients underwent TKA, and 31,769 underwent THA. Of these, 179 (0.20 %) were diagnosed with symptomatic PE, 470 (0.52 %) were diagnosed with DVT, and 106 (0.12 %) died during the first 3 months after surgery. Mean hospital stay was significantly longer in patients who developed VTE than in those who did not. Of 106 patients who died, 20 (19 %) had been diagnosed with PE.
The first step in diagnosis VTE is the suspicion. Acute VTE should be suspected in patients with a combination of suggestive symptoms and/or signs. Most patients with confirmed PE do not have clinically evident DVT, and around 30 % of patients with symptomatic DVT have asymptomatic PE. The objectives of VTE treatment are to improve acute symptoms and to prevent thrombus extension, early recurrence, and death from PE. In most patients, the initial treatment of DVT and PE is similar since both conditions are considered different manifestations of the same disease. Anticoagulation remains the mainstay of VTE treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Guijarro R, Montes J, San Román C, Arcelus JI, Barillari G, Granero X, Monreal M. Venous thromboembolism and bleeding after total knee and hip arthroplasty. Findings from the Spanish National Discharge Database. Thromb Haemost. 2011;105:610–5.
Arcelus JI, Caprini JA, Monreal M, Suárez C, González-Fajardo J. The management and outcome of acute venous thromboembolism: a prospective registry including 4011 patients. J Vasc Surg. 2003;38:916–22.
Laporte S, Mismetti P, Découssus H, Uresandi F, Otero R, Lobo JL, Monreal M, RIETE Investigators. Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism; findings from the registro informatizado de la enfermedad tromboembólica venosa (RIETE) Registry. Circulation. 2008;117:1711–6.
Arcelus JI, Monreal M, Caprini JA, Guisado JG, Soto MJ, Núñez MJ, Alvárez JC. Clinical presentation and time-course of postoperative venous thromboembolism. Findings from the RIETE Registry. Thromb Haemost. 2008;99:546–51.
www.riete.org. Accessed on 2 May 2011.
Wells PS, Lensing AWA, Davidson BL, Prins MH, Hirsh J. Accuracy of ultrasound for diagnosis of deep venous thrombosis in asymptomatic patients after orthopedic surgery. A meta-analysis. Ann Intern Med. 1995;122:47–53.
Robinson KS, Anderson DR, Gross M, Petrie D, Leighton R, Stanish W, Alexander D, Mitchell M, Flemming B, Gent M. Ultrasonographic screening before hospital discharge for deep venous thrombosis after arthroplasty: the post-arthroplasty screening study. A randomized, controlled trial. Ann Intern Med. 1997;127:439–45.
Leclerc JR, Gent M, Hirsh J, Geerts WH, Ginsberg JS, for the Canadian Collaborative Group. The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin. A multi-institutional cohort study of patients who underwent hip or knee arthroplasty. Arch Intern Med. 1998;158:873–8.
Verlato F, Bruchi O, Prandoni P, Camporese G, Maso G, Busonera F, Girolami A, Andreozzi GM, for the WODOS Investigators Group. The value of ultrasound screening for proximal vein thrombosis after total hip arthroplasty. A prospective cohort study. Thromb Haemost. 2001;86:534–7.
Schmidt B, Michler R, Klein M, Faulmann G, Weber C, Schellong S. Ultrasound screening for distal vein thrombosis is not beneficial after major orthopedic surgery. A randomized controlled trial. Thromb Haemost. 2003;90:949–54.
Schellong SM, Beyer J, Kakkar AK, Halbritter K, Eriksson BI, Turpie AGG, Misselwitz F, Kälebo P. Ultrasound screening for asymptomatic deep vein thrombosis after major orthopaedic surgery: the VENUS study. J Thromb Haemost. 2007;5:14311437.
Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell W. Prevention of venous thromboembolism. American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133:381S–453.
Monreal M, Peidro L, Resines C, Garcés C, Fernández JL, Garagorri E, González JC, NETCOT Investigators. Limited diagnostic workup for deep vein thrombosis after major joint surgery: findings from a prospective, multicentre, cohort study. Thromb Haemost. 2008;99:1112–5.
Scottish Intercollegiate Guidelines Network (SIGN). Prevention and management of venous thromboembolism. 2010; Edinburgh.
Wells PS, Anderson DR, Rodger M, Ginsberg JS, Kearon C, Gent M, et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost. 2000;83:416–20.
Torbicky A, Perrier A, Konstantinides S, Agnelli G, Gallie N, Pruszczyk P, et al. Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2008;29:2276–315.
Barritt DW, Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial. Lancet. 1960;i:1309–12.
Aschwanden M, Labs KH, Engel H, et al. Acute deep vein thrombosis: early mobilization does not increase the frequency of pulmonary embolism. Thromb Haemost. 2001;85:42–6.
Trujillo-Santos J, Perea-Milla E, Jimenez-Puente A, et al. Bed rest or ambulation in the initial treatment of patients with acute deep vein thrombosis or pulmonary embolism: findings from the RIETE registry. Chest. 2005;127:1631–6.
Partsch H, Blattler W. Compression and walking versus bed rest in the treatment of proximal deep venous thrombosis with low molecular weight heparin. J Vasc Surg. 2000;32:861–9.
Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133:454–545.
Dolovich LR, Ginsberg JS, Douketis JD, Holbrook AM, Cheah G. A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism. Arch Intern Med. 2000;24:181–8.
Van Dogen CJ, MacGillavry MR, Prins MH. Once versus twice daily LMWH for the initial treatment of venous thromboembolism. Cochrane Database Syst Rev. 2005;(3):CD003074.
Othieno R, Abu Affan M, Okpo E. Home versus in-patient treatment for deep vein thrombosis. Cochrane Database Syst Rev. 2007;(3):CD003076.
Büller HR, Davidson B, Decousus H, et al. Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis. A randomized trial. Ann Intern Med. 2004;140:867–73.
Matisse Investigators. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med. 2003;349:1695–702.
Lee A, Levine M, Naker R, et al. Low molecular weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med. 2003;349:146–53.
Watson LI, Armon MP. Thrombolysis for acute deep vein thrombosis. Cochrane Database Syst Rev. 2004;(4):CD002783.
Enden T, Klow N-E, Sandvik L, et al. Catheter-directed thrombolysis versus anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short term patency. J Thromb Haemost. 2009;7:1268–75.
Vendantham S. Catheter-directed thrombolysis for deep vein thrombosis. Curr Opin Hematol. 2010;17:464–8.
Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena cava filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med. 1998;338:409–16.
Iorio A, Guercini F, Pini M. Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants. J Thromb Haemost. 2003;1:1906–13.
Hull R, Pineo G, Brant R, et al. Long-term low-molecular-weight heparin versus usual care in proximal vein thrombosis patients with cancer. Am J Med. 2006;119:1062–72.
Cosmi B, Legnani C, Tosetto A, et al. Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study. Blood. 2010;115:481–8.
Palareti G, Cosmi B, Legnani C, et al. D-dimer testing to determine the duration of anticoagulant therapy. N Engl J Med. 2006;355:1780–9.
Prandoni P, Prins MH, Lensing AW, et al. Residual vein thrombosis to guide the duration of anticoagulation I patients with deep venous thrombosis: a randomized trial. Ann Intern Med. 2009;150:577–85.
Brandjes DP, Büller HR, Heijboer H, et al. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet. 1997;349:759–62.
Prandoni P, Lensing AW, Prins MH, et al. Below-knee stockings elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann Intern Med. 2004;141:249–56.
The EINSTEIN Investigators. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med. 2010;363:2499–510.
Schulman S, Kearon C, Kakkar AK, et al. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med. 2009;361:2342–52.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Monreal, M., Arcelus, J.I. (2013). Diagnosis and Treatment of Deep Vein Thrombosis and Pulmonary Embolism After Major Joint Surgery. In: Llau, J. (eds) Thromboembolism in Orthopedic Surgery. Springer, London. https://doi.org/10.1007/978-1-4471-4336-9_4
Download citation
DOI: https://doi.org/10.1007/978-1-4471-4336-9_4
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-4335-2
Online ISBN: 978-1-4471-4336-9
eBook Packages: MedicineMedicine (R0)